Primary open-angle glaucoma (POAG) is the most common form of glaucoma, a condition where the optic nerve at the back of your eye gradually deteriorates, leading to progressive vision loss. It affects roughly 63 million people worldwide over age 40, and that number is projected to reach 154 million by 2060. What makes POAG particularly dangerous is that it causes no symptoms in its early stages, so significant damage can accumulate before you notice anything wrong.
How the Eye’s Drainage System Fails
Your eye constantly produces a clear fluid that nourishes its internal structures and maintains its shape. This fluid drains out through a tiny mesh-like tissue called the trabecular meshwork, located where the iris meets the cornea. In POAG, this drainage tissue becomes increasingly resistant to fluid outflow, even though the drainage angle itself remains physically open (which is what “open angle” means). The fluid backs up, and pressure inside the eye rises gradually.
The dysfunction in the drainage tissue can take several forms: accumulated debris clogging the mesh, a decrease in the cells that line the drainage channels, or a reduction in the microscopic pores that allow fluid to pass through. The result is the same. Fluid builds up, internal eye pressure increases, and the optic nerve begins to sustain damage. Two mechanisms drive that damage: the elevated pressure physically compresses the nerve fibers, and it disrupts blood flow to the nerve, starving it of oxygen and essential growth factors.
Why It’s Called the “Silent Thief of Sight”
POAG produces no pain, no redness, and no noticeable vision changes in its early stages. The first visual losses are patchy blind spots in your peripheral (side) vision, which your brain readily compensates for. Most people don’t realize anything is wrong until the disease has progressed enough to affect central vision, the sharp, straight-ahead vision you use for reading and recognizing faces. By that point, the nerve damage is irreversible. This is why routine eye exams are critical for catching glaucoma before it steals vision you can’t get back.
Who Is Most at Risk
Age is the strongest risk factor. POAG rarely appears before 40, and risk climbs steadily with each decade. Family history also matters significantly. If a parent or sibling has glaucoma, your own risk is substantially higher.
Race and ethnicity play a major role. Black individuals develop POAG at younger ages, are roughly twice as likely to develop early-stage disease compared to white individuals, and face a dramatically higher risk of advanced vision loss, with one large cohort study finding they were over six times more likely to develop advanced visual field damage. Genetically determined African ancestry has been independently associated with greater glaucoma risk, regardless of other factors. Hispanic individuals also face elevated risk for certain patterns of vision loss, particularly those affecting central and near-central vision.
Other risk factors include high eye pressure readings, thin corneas (which can make pressure measurements misleadingly low), and high myopia (nearsightedness), which is expected to drive much of the projected increase in POAG cases over the coming decades.
Normal Pressure Doesn’t Mean No Glaucoma
Normal eye pressure falls between 10 and 21 mmHg. One of the most confusing aspects of POAG is that some people develop the exact same pattern of optic nerve damage while their pressure never exceeds the normal range. This is called normal-tension glaucoma, and it was traditionally treated as a separate disease. Recent evidence, however, suggests it’s better understood as part of a spectrum. At one end, glaucoma is driven primarily by high pressure. At the other end, vascular factors like poor blood flow to the optic nerve dominate, even when pressure is technically normal.
Research comparing patients with high-pressure POAG and normal-tension glaucoma found strikingly similar abnormalities in blood vessel function: increased blood pressure fluctuations at night, stiffer arteries, and reduced blood flow to the eye. Both groups also showed abnormal responses in the retinal blood vessels. This overlap is why lowering eye pressure helps slow the disease in both forms, and why your eye doctor looks at more than just the pressure number when assessing your risk.
How POAG Is Diagnosed
A comprehensive glaucoma evaluation involves several complementary tests, each revealing a different piece of the puzzle.
- Tonometry measures the pressure inside your eye. It’s quick, painless, and often done with a puff of air or a small probe that briefly touches the eye’s surface.
- Gonioscopy uses a special lens placed on the eye to directly examine the drainage angle, confirming that it’s open (ruling out angle-closure glaucoma).
- Pachymetry measures corneal thickness, which affects the accuracy of pressure readings. A thinner cornea can cause pressure to read artificially low.
- Optic nerve evaluation is done with a magnifying lens. The doctor examines the cup-to-disc ratio, a measurement of how much of the nerve head has been hollowed out. A normal average is around 0.4, and ratios of 0.7 or higher occur in only about 5% of healthy eyes.
- Optical coherence tomography (OCT) provides a high-resolution cross-sectional scan of the retinal nerve fiber layer. Thinning of this layer is structural evidence of glaucoma damage and is one of the most reliable early indicators, sometimes catching disease before vision loss shows up on other tests.
- Visual field testing maps your peripheral and central vision using automated perimetry, detecting blind spots you may not be aware of.
The American Academy of Ophthalmology recommends a baseline comprehensive eye evaluation at age 40, with follow-up intervals based on your individual risk profile. People with risk factors like family history, African ancestry, or high myopia generally need more frequent exams.
Treatment Options
All current treatments aim to lower eye pressure, even in cases of normal-tension glaucoma. Vision already lost to nerve damage cannot be restored, so the goal is to slow or halt further progression.
Eye Drops
Most people start with prescription eye drops. The most commonly prescribed type works by improving fluid drainage through the eye’s natural outflow pathways. A second class works by reducing the amount of fluid the eye produces in the first place. Other drop types use different mechanisms to achieve similar pressure-lowering effects. Many people end up using a combination, and the drops are typically a daily or twice-daily routine for life.
Laser Treatment
Selective laser trabeculoplasty (SLT) uses short pulses of laser energy to stimulate the drainage tissue, improving outflow without damaging surrounding structures. It’s performed in an office setting, takes just a few minutes, and has a low complication rate. In studies, SLT reduced eye pressure by about 31% over three years, from roughly 20 mmHg to about 14 mmHg. It also allowed some patients to reduce the number of eye drop medications they needed. SLT is increasingly used as a first-line treatment rather than a backup option, and it can be repeated if the effect wears off over time.
Minimally Invasive Glaucoma Surgery
When drops and laser aren’t enough, minimally invasive procedures use tiny devices or small incisions to create new drainage pathways inside the eye. These are often performed during cataract surgery. Studies show pressure reductions comparable to SLT (around 30%), though they were less effective at reducing the number of medications patients needed afterward. These procedures serve as a middle step between laser treatment and more traditional glaucoma surgeries, which create external drainage channels and carry higher risk but achieve greater pressure reduction for advanced disease.
Living With POAG
POAG is a lifelong condition that requires ongoing monitoring. Even with successful treatment, pressure can fluctuate (it naturally runs higher in the morning), and the optic nerve can continue to deteriorate slowly. Most eye doctors schedule follow-up visits every three to six months, using OCT scans and visual field tests to track whether the disease is stable or progressing.
The practical reality for most people is daily eye drops, periodic office visits, and possibly laser or surgical interventions if the disease advances. The earlier POAG is caught, the more vision you keep. People diagnosed with mild disease and treated promptly often maintain functional vision throughout their lives. Those diagnosed late, after significant nerve damage has already occurred, face a harder road, with fewer options and less margin for error.